303
Views
12
CrossRef citations to date
0
Altmetric
Letter to the Editor

Resolution of Acanthamoeba Keratitis with Adjunctive Use of Oral Miltefosine

, MD, , MD, , MD, , MD, , BA, , OD, , MD, , MD & , MD show all
Pages 278-281 | Received 12 Feb 2019, Accepted 18 Nov 2019, Published online: 12 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhuangjun Si, Peter B. Veldman, James J. Reidy & Asim V. Farooq. (2022) Severe Inflammatory Response in a Patient on Oral Miltefosine for Acanthamoeba Keratitis. Ocular Immunology and Inflammation 30:4, pages 1027-1028.
Read now
Brian Shing, Mina Balen, James H. McKerrow & Anjan Debnath. (2021) Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs. Expert Review of Anti-infective Therapy 19:11, pages 1427-1441.
Read now

Articles from other publishers (10)

Lenu B. Fakae, Mohammad S.R. Harun, Darren Shu Jeng Ting, Harminder S. Dua, Gareth W.V. Cave, Xing-Quan Zhu, Carl W. Stevenson & Hany M. Elsheikha. (2023) Camellia sinensis solvent extract, epigallocatechin gallate and caffeine confer trophocidal and cysticidal effects against Acanthamoeba castellanii. Acta Tropica 237, pages 106729.
Crossref
Lin Chen, Liangju Kuang, Amy E. Ross, Wissam Farhat, Nikolay Boychev, Sina Sharfi, Levi N. Kanu, Longqian Liu, Daniel S. Kohane & Joseph B. Ciolino. (2022) Topical Sustained Delivery of Miltefosine Via Drug-Eluting Contact Lenses to Treat Acanthamoeba Keratitis. Pharmaceutics 14:12, pages 2750.
Crossref
Colton McCoy, Shaivi Patel & Praneetha Thulasi. (2022) Update on the Management of Acanthamoeba Keratitis. Current Ophthalmology Reports 10:4, pages 153-161.
Crossref
Hwi Yeong Yoon & Hyun Sun Jeon. (2022) Diagnosis and Management of Acanthamoeba Keratitis. Annals of Optometry and Contact Lens 21:3, pages 104-108.
Crossref
Martin de la Presa, Mitch Ibach, John Berdahl & Edward J. Holland. (2022) Anterior Scleral and Limbal Inflammatory Necrosis After Adjuvant Miltefosine for Recalcitrant Acanthamoeba Keratitis. Cornea 41:6, pages 775-778.
Crossref
Clarissa Smith, Nida Ashraf, Megan Haghnegahdar, Kenneth Goins & Jessica R Newman. (2022) Acanthamoeba Keratitis: A Single-Institution Series of Four Cases With Literature Review. Cureus.
Crossref
Lauren Jeang & Sonal S. Tuli. (2022) Therapy for contact lens-related ulcers. Current Opinion in Ophthalmology Publish Ahead of Print.
Crossref
. (2022) Multiple drugs. Reactions Weekly 1888:1, pages 254-254.
Crossref
Praneetha Thulasi, Hajirah N. Saeed, Christopher J. Rapuano, Joshua H. Hou, Alpheus B. Appenheimer, James Chodosh, Joann J. Kang, Amber M. Morrill, Neil Vyas, Michael E. Zegans, Richard Zuckerman & Elmer Y. Tu. (2021) Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis. American Journal of Ophthalmology 223, pages 75-82.
Crossref
So-Min Park, Hae-Ahm Lee, Ki-Back Chu, Fu-Shi Quan, Su-Jung Kim & Eun-Kyung Moon. (2020) Production of a polyclonal antibody against inosine-uridine preferring nucleoside hydrolase of Acanthamoeba castellanii and its access to diagnosis of Acanthamoeba keratitis. PLOS ONE 15:9, pages e0239867.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.